Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program

Back

ESC Premium Access

Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program

Session: Tailoring antithrombotics according to bleeding risk

Topic: Thrombosis and coagulation

Speaker: Professor M. Huisman (Leiden, NL)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Menno Huisman

Leiden University Medical Center, Leiden (Netherlands (The))

15 presentations

1 follower

4 more presentations in this session

State of the art in tailoring antithrombotics according to bleeding risk.

Speaker: Professor F. Andreotti (Rome, IT)

Access

Impact of previous exposure to oral anticoagulants on the risk of death or rehospitalization in patients with acute coronary syndrome - analysis according to the anticipated risk of bleeding.

Speaker: Doctor C. Ruivo (Leiria, PT)

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Speaker: Doctor G. Lemesle (Lille, FR)

Future direction for research in tailoring according to bleeding risk.

Speaker: Professor R. De Caterina (Pisa, IT)

Access

Slides

Video

Access the full session

Tailoring antithrombotics according to bleeding risk

Speakers: Professor M. Huisman, Professor F. Andreotti, Doctor C. Ruivo, Doctor G. Lemesle, Professor R. De Caterina

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program

About the speaker

Professor Menno Huisman

4 more presentations in this session

State of the art in tailoring antithrombotics according to bleeding risk.

Impact of previous exposure to oral anticoagulants on the risk of death or rehospitalization in patients with acute coronary syndrome - analysis according to the anticipated risk of bleeding.

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Future direction for research in tailoring according to bleeding risk.

Access the full session

Tailoring antithrombotics according to bleeding risk

About the event

ESC Congress 2016

ESC 365 is supported by